Compare Enveric Biosciences Inc (ENVB) vs Microsoft (MSFT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Microsoft — how do they compare? Enveric Biosciences Inc trades at $1.35 (market cap $5.32M), while Microsoft trades at $393.28 (market cap $2.94T). The key difference: Microsoft is far larger — about 552631.6× Enveric Biosciences Inc's market cap, and Microsoft pays a 0.92% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | MSFT | |
|---|---|---|
Market Cap | $5.32M | $2.94T |
Sector | Health | Technology |
52-Week High | $17.40 | $542.07 |
52-Week Low | $1.28 | $352.83 |
Enterprise Value | $408.82K | $2.92T |
Volume | — | 36,654,621 |
Dividend Yield | — | 0.92% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Microsoft (MSFT) trades at $384.93, down 1.55% on the day, with technical indicators showing a bearish short-term trend. Fundamentally, the company demonstrates robust financial health with consistent earnings beats, strong revenue growth to $281.72B in 2025, and impressive net income margins of 39.34%. Recent news highlights Microsoft's leadership in AI and cloud computing, though investor concerns about rising capital expenditures have pressured the stock.
The outlook remains positive given strong fundamentals, a dominant market position, and an 80% analyst buy rating with a $547.23 consensus price target. Key opportunities include AI-driven growth via Azure and Copilot, while risks involve intense competition, high valuation multiples, and significant capital investment requirements that may pressure near-term free cash flow.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Microsoft
Microsoft Corporation develops, manufactures, licenses, sells, and supports software products. The Company offers operating system software, server application software, business and consumer applications software, software development tools, and Internet and intranet software. Microsoft also develops video game consoles and digital music entertainment devices.
Read more on MSFT →
